NKGen Biotech Announces Appointment of Philip Moody as Chief Financial Officer

SANTA ANA, Calif., April 07, 2021 (GLOBE NEWSWIRE) -- NKGen Biotech, a biotechnology company harnessing the power of the body's immune system through the development of Natural Killer (NK) cell therapies, today announced that it has appointed Philip Moody as its Chief Financial Officer (CFO). Mr. Moody is a...

Click to view original post